DocDollars

Biodelivery Sciences International, Inc.

MA · United States · Reporting entity ID 100000061387

Total reported 2019–2025
$2.65M
#929 of 2,960 reporting companies — 0% of all reported industry payments
$1.45M in general payments across 32,816 records, plus $1.21M in research funding across 21 records.

How it breaks down

General payments $1,447,284
Research funding $1,205,065

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Biodelivery Sciences International, Inc. reported $2.65M to US doctors and teaching hospitals from 2019 to 2025, ranking #929 of 2,960 reporting companies. 45% of that was research funding and 55% general payments such as consulting, speaking, food and travel. 32,816 general payment records and 21 research records were filed.

Common questions about Biodelivery Sciences International, Inc.

How much has Biodelivery Sciences International, Inc. paid US doctors?

Biodelivery Sciences International, Inc. reported $2,652,349 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,447,284 in general payments, $1,205,065 in research funding.

How does Biodelivery Sciences International, Inc. rank among drug and device companies?

It ranks #929 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Biodelivery Sciences International, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.